Manulife (Manufacturers Life Insurance)’s Monopar Therapeutics MNPR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MNPR Stock Details MNPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$251K	Buy	+4,572	New	+$276K	﹤0.01%	2383

Other funds holding MNPR

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s MNPR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in Monopar Therapeutics (MNPR) in Q1 2026: 4,572 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #2383 among its holdings.

82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 4,572 shares of Monopar Therapeutics worth $251K as of Q1 2026.
Monopar Therapeutics was a new Manulife (Manufacturers Life Insurance) position in Q1 2026.
Monopar Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2383 holding.
82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.